Page 138 - 《中国药房》2026年3期

human umbilical cord blood-derived mesenchymal stem [30] XIE M L，PALLEGAR P N，PARUSEL S，et al. Regula‐
cells reduces aberrant tau phosphorylation in an Alzheimer’s tion of cortical hyperexcitability in amyotrophic lateral
disease model[J]. Stem Cells Int，2020，2020：8878412. sclerosis：focusing on glial mechanisms[J]. Mol Neurode‐
[19] WANG Y X，JIANG J L，FU X Q，et al. Fe3O4@polydopa‐ gener，2023，18（1）：75.
mine nanoparticle-loaded human umbilical cord mesen‐ [31] WANG J，HU W W，FENG Z H，et al. BDNF-
chymal stem cells improve the cognitive function in overexpressing human umbilical cord mesenchymal stem
Alzheimer’s disease mice by promoting hippocampal neu‐ cell-derived motor neurons improve motor function and
rogenesis[J]. Nanomedicine，2022，40：102507. prolong survival in amyotrophic lateral sclerosis mice[J].
[20] KIM H J，CHO K R，JANG H，et al. Intracerebroventricu‐ Neurol Res，2021，43（3）：199-209.
lar injection of human umbilical cord blood mesenchymal [32] KOOK M G，LEE S，SHIN N，et al. Repeated intramuscu‐
stem cells in patients with Alzheimer’s disease dementia： lar transplantations of hUCB-MSCs improve motor func‐
a phase Ⅰ clinical trial[J]. Alzheimers Res Ther，2021，13 tion and survival in the SOD1 G A mice through activa‐
93
（1）：154. tion of AMPK[J]. Sci Rep，2020，10（1）：1572.
[21] MYEONG S H，KIM H，LEE N K，et al. Intracerebroven‐ [33] ALIDOUST L，AKHOONDIAN M，ATEFI A H，et al.
tricular administration of human umbilical cord blood- Stem cell-conditioned medium is a promising treatment
derived mesenchymal stem cells induces transient inflam‐ for Alzheimer’s disease[J]. Behav Brain Res，2023，452：
mation in a transgenic mouse model and patients with 114543.
Alzheimer’s disease[J]. Biomedicines，2022，10（3）：563. [34] TANG J S，KANG Y Y，ZHOU Y J，et al. Umbilical cord
[22] SUN Z Q，GU P，XU H J，et al. Human umbilical cord mesenchymal stem cell-conditioned medium inhibits mi‐
mesenchymal stem cells improve locomotor function in croglial activation to ameliorate neuroinflammation in
Parkinson’s disease mouse model through regulating in‐ amyotrophic lateral sclerosis mice and cell models[J].
testinal microorganisms[J]. Front Cell Dev Biol，2022，9： Brain Res Bull，2023，202：110760.
808905. [35] LAN J Q，ZHOU Y J，WANG H Y，et al. Protective effect
[23] HE Y，LI R C，YU Y X，et al. HucMSC extracellular of human umbilical cord mesenchymal stem cell-derived
vesicles increase SATB 1 to activate the Wnt/β -catenin conditioned medium in a mutant TDP-43 induced
pathway in 6-OHDA-induced Parkinson’s disease model motoneuron-like cellular model of ALS[J]. Brain Res
[J]. IUBMB Life，2024，76（12）：1154-1174. Bull，2023，193：106-116.
[24] CHEN H X，LIANG F C，GU P，et al. Exosomes derived [36] BARCZEWSKA M，MAKSYMOWICZ S，ZDOLIŃSKA-
from mesenchymal stem cells repair a Parkinson’s disease MALINOWSKA I，et al. Umbilical cord mesenchymal
model by inducing autophagy[J]. Cell Death Dis，2020，11 stem cells in amyotrophic lateral sclerosis：an original
（4）：288. study[J]. Stem Cell Rev Rep，2020，16（5）：922-932.
[25] ZHANG Z X，ZHOU Y J，GU P，et al. Exosomes derived [37] LING X，WANG T，HAN C，et al. IFN-γ-primed hUC‐
from human umbilical cord mesenchymal stem cells alle‐ MSCs significantly reduced inflammation via the Foxp3/
viate Parkinson’s disease and neuronal damage through ROR-γt/STAT3 signaling pathway in an animal model of
inhibition of microglia[J]. Neural Regen Res，2023，18 multiple sclerosis[J]. Front Immunol，2022，13：835345.
（10）：2291-2300. [38] LIU H X，CUI D Q，HUANGFU S S，et al. VCAM-1
+
[26] HUANG W X，ZHANG T，LI X D，et al. Intranasal mesenchymal stem/stromal cells reveal preferable efficacy
administration of umbilical cord mesenchymal stem cell upon an experimental autoimmune encephalomyelitis
exosomes alleviates Parkinson’s disease[J]. Neuroscience， mouse model of multiple sclerosis over the VCAM-1
2024，549：1-12. counterpart[J]. Neurochem Res，2024，50（1）：40.
[27] GENG Y，LONG X Y，ZHANG Y T，et al. FTO-targeted [39] MOHAMMADZADEH A，LAHOUTY M，CHARKHIAN
siRNA delivery by MSC-derived exosomes synergistically H，et al. Human umbilical cord mesenchymal stem cell-
alleviates dopaminergic neuronal death in Parkinson’s derived exosomes alleviate the severity of experimental
disease via m6A-dependent regulation of ATM mRNA[J]. autoimmune encephalomyelitis and enhance lag-3 expres‐
J Transl Med，2023，21（1）：652. sion on foxp3 CD4 T cells[J]. Mol Biol Rep，2024，51
+
+
[28] WANG C C，HU X M，LONG Y F，et al. Treatment of （1）：522.
Parkinson’s disease model with human umbilical cord [40] JAMALI F，ALDUGHMI M，ATIANI S，et al. Human um‐
mesenchymal stem cell-derived exosomes loaded with bilical cord-derived mesenchymal stem cells in the treat‐
BDNF[J]. Life Sci，2024，356：123014. ment of multiple sclerosis patients：phase Ⅰ/Ⅱ dose-
[29] GOUTMAN S A，HARDIMAN O，AL-CHALABI A， finding clinical study[J]. Cell Transplant，2024，33：
et al. Recent advances in the diagnosis and prognosis of 09636897241233045.
amyotrophic lateral sclerosis[J]. Lancet Neurol，2022，21 （收稿日期：2025-07-25 修回日期：2025-11-22）
（5）：480-493. （编辑：胡晓霖）

· 400 · China Pharmacy 2026 Vol. 37 No. 3 中国药房 2026年第37卷第3期